Bio-Techne Corp. (TECH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Halozyme Therapeutics, Inc.

Amgen, Inc.

Illumina, Inc.

Gilead Sciences, Inc.

Moderna, Inc.

Bio-Techne Corp.

BioMarin Pharmaceutical, Inc.

Biogen, Inc.

Elanco Animal Health, Inc.

Vaxcyte, Inc.

Immunovant, Inc.

Why is Bio-Techne Corp. ?

High Management Efficiency with a high ROE of 12.13%

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.39 times

Poor long term growth as Operating profit has grown by an annual rate 7.03% of over the last 5 years

Flat results in Dec 25

OPERATING CASH FLOW(Y) Lowest at USD 249.31 MM
INVENTORY TURNOVER RATIO(HY) Lowest at 2.06 times

With ROE of 10.77%, it has a very expensive valuation with a 3.80 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -14.15%, its profits have fallen by -6.8%

High Institutional Holdings at 100%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -14.15% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Bio-Techne Corp. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Bio-Techne Corp. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Bio-Techne Corp.

-13.72%

-0.72

44.75%

S&P 500

13.68%

0.71

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

8.76%

EBIT Growth (5y)

7.03%

EBIT to Interest (avg)

22.31

Debt to EBITDA (avg)

0.39

Net Debt to Equity (avg)

0.10

Sales to Capital Employed (avg)

0.50

Tax Ratio

19.21%

Dividend Payout Ratio

69.67%

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

13.55%

ROE (avg)

12.13%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.80

EV to EBIT

28.16

EV to EBITDA

20.44

EV to Capital Employed

3.66

EV to Sales

6.37

PEG Ratio

Dividend Yield

49.50%

ROCE (Latest)

13.01%

ROE (Latest)

10.77%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 1.37% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 8.85 %

DEBTORS TURNOVER RATIO(HY)

Highest at 5.97 times

-3What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD 249.31 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.06 times

Here's what is working for Bio-Techne Corp.

Debt-Equity Ratio

Lowest at 8.85 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 5.97 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by 1.37% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Bio-Techne Corp.

Operating Cash Flow

Lowest at USD 249.31 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Inventory Turnover Ratio

Lowest at 2.06 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio